Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Neurologia (Barcelona, Spain)
|
September 19, 2015
Myelitis: Differences between multiple sclerosis and other aetiologies
S Presas-Rodríguez, L Grau-López, J V Hervás-García, et al.
American Journal of Medical Genetics
|
June 19, 1995
Familial cosegregation of manic-depressive illness and a form of hereditary cerebellar ataxia
J Fernández Piqueras, J Santos, G Visedo, et al.
Autoimmunity Reviews
|
April 28, 2009
Myelin peptides in multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
European Journal of Neurology
|
July 14, 2011
Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
Journal of Translational Medicine
|
June 11, 2011
Comparative study of clinical grade human tolerogenic dendritic cells
M Naranjo-Gómez, D Raïch-Regué, C Oñate, et al.
European Journal of Neurology
|
June 22, 2010
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
V Devonshire, Y Lapierre, R Macdonell, et al.
European Journal of Neurology
|
October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
J V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses
L Grau-López, A Teniente-Serra, M Tintoré, et al.
Cellular & Molecular Immunology
|
May 7, 2021
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
M J Mansilla, S Presas-Rodríguez, A Teniente-Serra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
C Ramo-Tello, L Grau-López, M Tintoré, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Neurologia (Barcelona, Spain)
|
September 19, 2015
Myelitis: Differences between multiple sclerosis and other aetiologies
S Presas-Rodríguez, L Grau-López, J V Hervás-García, et al.
American Journal of Medical Genetics
|
June 19, 1995
Familial cosegregation of manic-depressive illness and a form of hereditary cerebellar ataxia
J Fernández Piqueras, J Santos, G Visedo, et al.
Autoimmunity Reviews
|
April 28, 2009
Myelin peptides in multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
European Journal of Neurology
|
July 14, 2011
Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
L Grau-López, D Raïch, C Ramo-Tello, et al.
Journal of Translational Medicine
|
June 11, 2011
Comparative study of clinical grade human tolerogenic dendritic cells
M Naranjo-Gómez, D Raïch-Regué, C Oñate, et al.
European Journal of Neurology
|
June 22, 2010
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
V Devonshire, Y Lapierre, R Macdonell, et al.
European Journal of Neurology
|
October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
J V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses
L Grau-López, A Teniente-Serra, M Tintoré, et al.
Cellular & Molecular Immunology
|
May 7, 2021
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
M J Mansilla, S Presas-Rodríguez, A Teniente-Serra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
C Ramo-Tello, L Grau-López, M Tintoré, et al.
Page
of 3